8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation

Autor: Jukka Kanerva, Fanny Lanternier, Monica A. Slavin, Elio Castagnola, Andreas H. Groll, Dina Averbuch, Alessio Mesini, Roland A. Ammann, Carolina Garcia-Vidal, Simone Cesaro, Malgorzata Mikulska, Nicole Ritz, Jan Styczyński, Dorothea Pana, Adilia Warris, Thomas Lehrnbecher
Přispěvatelé: HUS Children and Adolescents, Children's Hospital
Rok vydání: 2021
Předmět:
medicine.medical_specialty
medicine.drug_class
medicine.medical_treatment
3122 Cancers
Antibiotics
Placebo-controlled study
CHILDREN
Guidelines as Topic
Hematopoietic stem cell transplantation
PLACEBO-CONTROLLED TRIAL
INTRAVENOUS ANTIBIOTICS
Pediatrics
ANTIBACTERIAL PROPHYLAXIS
CIPROFLOXACIN PROPHYLAXIS
03 medical and health sciences
0302 clinical medicine
Internal medicine
medicine
Humans
030212 general & internal medicine
LACTAMASE-PRODUCING ENTEROBACTERIACEAE
RISK FEBRILE NEUTROPENIA
610 Medicine & health
Adverse effect
Leukemia
business.industry
Hematopoietic Stem Cell Transplantation
Cancer
Congresses as Topic
medicine.disease
Anti-Bacterial Agents
3. Good health
Discontinuation
ONCOLOGY PATIENTS
Mycoses
Oncology
030220 oncology & carcinogenesis
OUTPATIENT MANAGEMENT
BLOOD-STREAM INFECTIONS
business
Febrile neutropenia
Zdroj: The Lancet Oncology. 22:e270-e280
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(20)30725-7
Popis: Paediatric patients with cancer and those undergoing haematopoietic cell transplantation are at high risk of bacterial infections. The 8th European Conference on Infections in Leukaemia (ECIL-8) convened a Paediatric Group to review the literature and to formulate recommendations for the use of antibiotics according to the European Society of Clinical Microbiology and Infectious Diseases grading system. The evaluation of antibacterial prophylaxis included mortality, bloodstream infection, febrile neutropenia, emergence of resistance, and adverse effects as endpoints. Initial antibacterial therapy and antibiotic de-escalation or discontinuation focused on patients with a clinically stable condition and without previous infection or colonisation by resistant bacteria, and on patients with a clinically unstable condition or with previous infection or colonisation by resistant bacteria. The final considerations and recommendations of the ECIL-8 Paediatric Group on antibacterial prophylaxis, initial therapy, and de-escalation strategies are summarised in this Policy Review.
Databáze: OpenAIRE